Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

Publisher： John Wiley & Sons Inc

E-ISSN： 2047-9980|5|2|JAHA.115.002776-JAHA.115.002776

ISSN： 2047-9980

Source： JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.5, Iss.2, 2016-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation

By  

Current Cardiology Reviews, Vol. 10, Iss. 4, 2014-11 ,pp. : 297-302

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in

By van Walraven C.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 374-378

Springer Publishing Company

Access to resources Recommend Favorite

Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Non-Valvular Atrial Fibrillation

By  

Cerebrovascular Diseases, Vol. 21, Iss. 4, 2006-03 ,pp. : 279-293

Karger

Access to resources Recommend Favorite

Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 14-20

Bentham Science Publishers

Access to resources Recommend Favorite